4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-20-051507
Director bought 10,000 shares at $0.72 ($7,245)
From the SEC's structured data for this filing
Trades in this filing
Haddadin Yezan Munther · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-22 | Purchase : show line 1 in the form | +10,000 | $0.72 | $7,245 | 10,000 | D |
| Open-market purchases · 10,000 sh · avg $0.72 · $7,245 | ||||||
Loading xslF345X03/doc4.xml…